USPTO serial 79301461
CEREBRAIM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 2, 2021
- Examiner
- NOBLE, ANNIE MELISSA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with CEREBRAIM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for scientific and medical analysis of scientific research; data processing apparatus; downloadable artificial intelligence software for use in machine learning in the field of scientific research; downloadable artificial intelligence software for use in machine learning in the field of biotechnology, health and medical care; downloadable artificial intelligence software for use in data analysis for the purpose of creating personalised medicines; downloadable software that provides medical assessment in the nature of diagnosing medical conditions in real time based on artificial intelligence and using algorithm based machine learning technology; downloadable software for monitoring, analysing, controlling and running medical operations; downloadable electronic publications, namely, medical journals in the field of biotechnology, health and medical artificial intelligence software; downloadable teaching, instructional and educational material in the field of biotechnology, health and medical artificial intelligence software; downloadable electronic databases in the field of biotechnology, health and medical research | ACTIVE | — |
| 042 | Software as a service [SaaS] featuring software using artificial intelligence for use in machine learning in the field of biotechnology, health and medical care; platforms for artificial intelligence featuring software as a services [SaaS] for use in machine learning in the field of biotechnology, health and medical care; research in the field of artificial intelligence; providing on-line non-downloadable software for processing data in the field of biotechnology; software design and development services for others in the field of biotechnology, health and medical care; computer programming; computer systems design and development; research relating to the development of computer programs and software; research, development and testing of software and algorithms for biotechnology,medical and health care services; analysis of scientific data in the field of biotechnology, health and medical care for scientific research purposes; authentication and testing of pharmaceuticals; scientific, pharmaceutical and medical research and development services; scientific study in the field of personalised medicine research and development services; research, design, development and testing of new products; pharmaceutical products research, design, development and testing; research, design, development and testing services in the field of biotechnology; information, advisory and consultancy services relating to all the aforesaid; including all of the aforesaid services provided on-line from a computer database, intranets, extranets and the Internet | ACTIVE | — |
| 044 | Healthcare services; pharmaceutical compounding services; advisory services relating to pharmaceutical compounding services; medical analysis of healthcare and medical data; medical testing for diagnostic or treatment purposes; providing medical testing and reporting services for the susceptibility, risk, diagnosis, prognosis, treatment and management of diseases; real time support medical consultation services in the field of diagnostic medical decision making using algorithm-based machine learning; information, advisory and consultancy services relating to all the aforesaid; including all of the aforesaid services provided on-line from a computer database, intranets, extranets and the Internet | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cerebraim Limited
- Other trademarks owned by Cerebraim Limited
- Other trademarks owned by Cerebraim Limited
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CEREBRAIM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 27, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 27, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 27, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 27, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 27, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 16, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 25, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 25, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 2, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 2, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 17, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 17, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 15, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 28, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 28, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 28, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 14, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 1, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 30, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 30, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 21, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 1, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 1, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 14, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 13, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 12, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 8, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 8, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 7, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |